The inhibited expression of many CTAs (such as NY‐ESO‐1, MAGE‐A1, and MAGE‐A3) in tumor cells is consistent with DNA hypermethylation and histone heterochromatin modification in the promoters of these genes. Here, MAGEA3 is linked to neoplasm.